This inventor holds 3 USPTO granted patents. Top assignees: Sanofi, Labaz. Active years: 1979-1987.
Company Filing History:
Years Active: 1979-1987
Title: The Innovations of Maurice Prost
Introduction
Maurice Prost is a notable inventor based in Brussels, Belgium. He has made significant contributions to the field of pharmaceuticals, particularly through his innovative work on decahydroquinolinol derivatives. With a total of 3 patents to his name, Prost's inventions have the potential to impact the treatment of cardiovascular diseases.
Latest Patents
Prost's latest patents include novel decahydroquinolinol derivatives and pharmaceutical compositions. These inventions relate to compounds represented by a specific general formula, which are designed to act as inhibitors of calcium translocation at the cell membrane. This mechanism is particularly useful in treating pathological syndromes of the cardiovascular system, such as angina pectoris. Another patent focuses on decahydroquinolinol derivatives that correspond to a different general formula, which also aims to provide therapeutic benefits for cardiac conditions.
Career Highlights
Throughout his career, Maurice Prost has worked with prominent companies in the pharmaceutical industry, including Sanofi and Labaz. His experience in these organizations has allowed him to develop and refine his innovative ideas, contributing to advancements in medical treatments.
Collaborations
Prost has collaborated with notable individuals in his field, including Michel De Claviere and Peter Polster. These partnerships have likely enriched his research and development efforts, fostering a collaborative environment for innovation.
Conclusion
Maurice Prost's contributions to the field of pharmaceuticals through his patents on decahydroquinolinol derivatives highlight his role as an influential inventor. His work continues to pave the way for advancements in the treatment of cardiovascular diseases.